
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp has demonstrated robust performance, with organic sales increasing by 5%, indicative of strong demand dynamics across its key segments. The healthcare sector is particularly noteworthy, achieving double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Additionally, four out of nine end markets that constitute 40% of Avient's sales are experiencing growth, suggesting a diversified portfolio that is resilient amid challenges in certain markets, positioning the company favorably for future financial performance.
Bears say
Avient Corp is experiencing a decline in organic sales, with a notable drop of approximately 2% in the first quarter of 2024, suggesting potential instability in revenue generation. The weakening demand for chemicals, anticipated to further affect sales volumes in the second half of 2025, raises concerns regarding the company's future performance. Additionally, despite a slight depreciation of the dollar providing some potential tailwinds, the overall market challenges could overshadow this benefit and impact Avient's profitability negatively.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares